Mr. Louis E. Silverman's most recent trade in Insight Molecular Diagnostics Inc. was a trade of 7,700 Common Stock, no par value done at an average price of $5.7 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Insight Molecular Diagnostics Inc | Mr. Louis E. Silverman | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.69 per share. | 01 Jul 2026 | 7,700 | 55,807 (0%) | 0% | 5.7 | 43,813 | Common Stock, no par value |
| Staar Surgical Co. | Mr. Louis E. Silverman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2026 | 10,683 | 11,158 (0%) | 0% | 0 | Common Stock | |
| Staar Surgical Co. | Mr. Louis E. Silverman | Director | 18 Jun 2026 | 10,683 | 0 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Mr. Louis E. Silverman | Director | 18 Jun 2026 | 6,182 | 6,182 | - | - | Restricted Stock Units | ||
| Insight Molecular Diagnostics Inc | Mr. Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 26,943 | 63,507 (0%) | 0% | 0 | Common Stock, no par value | |
| Insight Molecular Diagnostics Inc | Mr. Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 35,000 | 36,564 (0%) | 0% | 0 | Common Stock, no par value | |
| Staar Surgical Co. | Mr. Louis E. Silverman | Director | 18 Jun 2025 | 10,683 | 10,683 | - | - | Restricted Stock Units | ||
| Staar Surgical Co. | Mr. Louis E. Silverman | Director | 12 May 2025 | 2,440 | 2,440 | - | - | Common Stock Options | ||
| Insight Molecular Diagnostics Inc | Mr. Louis E. Silverman | Director | 01 Jul 2024 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | ||
| Insight Molecular Diagnostics Inc | Mr. Louis E. Silverman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 25,000 | 31,270 (0%) | 0% | 0 | - |